Non Alcoholic Fatty Liver Disease Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
ETNB | F | 89bio, Inc. | -2.09 | |
AKRO | F | Akero Therapeutics, Inc. | -0.77 | |
ALGS | D | Aligos Therapeutics, Inc. | 0.12 | |
BLTE | C | Belite Bio, Inc. | 0.09 | |
BFRG | F | Bullfrog AI Holdings, Inc | -3.97 | |
GNFT | D | GENFIT S.A. | 0.57 | |
GALT | B | Galectin Therapeutics Inc. | -2.68 | |
GLTO | F | Galecto, Inc. | 0.31 | |
GYRE | D | Gyre Therapeutics, Inc. | 1.48 | |
IVA | F | Inventiva S.A. | -1.46 |
Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic Health Information Services
Related Stock Lists:
Steatohepatitis
Hepatitis
Alcohol
Liver Disease
Medicine
Biopharmaceutical
Clinical Medicine
Fibrosis
Biology
Biotechnology
Breakthrough Therapy
Cancer
Drug Development
Fatty Liver Disease
Fibrotic Disease
Galectin
Galectin 3
Galecto Biotech
Idiopathic Pulmonary Fibrosis
Lectins
Related ETFs - A few ETFs which own one or more of the above listed Non Alcoholic Fatty Liver Disease stocks.
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
SURI | D | Simplify Exchange Traded Funds Simplify Propel Opportunities ETF | 4.85 | |
BBC | D | Virtus LifeSci Biotech Clinical Trials ETF | 2.13 | |
SBIO | D | ALPS Medical Breakthroughs ETF | 1.25 | |
XBI | D | SPDR S&P Biotech ETF | 1.19 | |
LABU | D | Direxion Daily S&P Biotech Bull 3X Shares | 0.72 |
Compare ETFs
Related Industries:
Biotechnology
Drug Manufacturers - Specialty & Generic
Health Information Services
Related Stock Lists:
Steatohepatitis
Hepatitis
Alcohol
Liver Disease
Medicine
Biopharmaceutical
Clinical Medicine
Fibrosis
Biology
Biotechnology
Breakthrough Therapy
Cancer
Drug Development
Fatty Liver Disease
Fibrotic Disease
Galectin
Galectin 3
Galecto Biotech
Idiopathic Pulmonary Fibrosis
Lectins
- Non Alcoholic Fatty Liver Disease
Non-alcoholic fatty liver disease (NAFLD) is a condition in which fat builds up in the liver, causing inflammation and damage. It is the most common form of liver disease in the United States, affecting up to 25% of the population. NAFLD is closely linked to obesity, diabetes, and high cholesterol, and can lead to serious complications such as cirrhosis and liver cancer. Treatment typically involves lifestyle changes such as weight loss, exercise, and a healthy diet.
Popular Now
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Featured Articles